Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Pouwels KB. et al, (2021)

Public preferences for delayed or immediate antibiotic prescriptions in UK primary care: a choice experiment

MORRELL E., (2021), PLoS Medicine

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom

Wei J. et al, (2021), Nature Microbiology

Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time

Walker AS. et al, (2021), eLife, 10

Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom.

Pritchard E. et al, (2021), Nature medicine

Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom.

Pritchard E. et al, (2021), Nat Med

Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status

EYRE D. et al, (2021), Clinical Microbiology and Infection

Impact of vaccination on new SARS-CoV-2 infections in the UK

PRITCHARD E. et al, (2021), Nature Medicine

Local prevalence of transmissible SARS-CoV-2 infection: an integrative causal model for debiasing fine-scale targeted testing data

Nicholson G. et al, (2021)

Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom

Pritchard E. et al, (2021)

The impact of SARS-CoV-2 vaccines on antibody responses in the general population in the United Kingdom

Wei J. et al, (2021)

Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status

Eyre D. et al, (2021)

An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status

Lumley SF. et al, (2021)

Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom

BUCHANAN J. et al, (2021), Applied Health Economics and Health Policy

Increased infections, but not viral burden, with a new SARS-CoV-2 variant

Walker AS. et al, (2021)

Implementing interventions to reduce antibiotic use: A qualitative study in high-prescribing practices

BOREK A. et al, (2021), BMC Family Practice

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.

Lumley SF. et al, (2020), The New England journal of medicine

The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers

Lumley SF. et al, (2020), Clinical Infectious Diseases

Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey

POUWELS K. et al, (2020), Lancet Public Health

Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey

POUWELS K. et al, (2020), Lancet Public Health

Load More

Handbooks in Health Economic Evaluation

A series published by Oxford University Press.

Find out more